Poly Medicure Ltd

Poly Medicure Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Poly Medicure Ltd

₹ 2,219 -0.03%
11 Jul - close price
polymedicure.com BSE: 531768 NSE: POLYMED
About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

Key Points

Product Portfolio
It is a medical devices company with a product portfolio comprised of 200+ SKUs of medical devices across 12 specialties including therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. [1]

Website BSE NSE
  • Market Cap ₹ 22,484 Cr.
  • Current Price ₹ 2,219
  • High / Low ₹ 3,358 / 1,788
  • Stock P/E 66.4
  • Book Value ₹ 273
  • Dividend Yield 0.14 %
  • ROCE 20.2 %
  • ROE 16.0 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 28.7% CAGR over last 5 years

Cons

  • Stock is trading at 8.13 times its book value
  • Working capital days have increased from 185 days to 344 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
258 249 275 285 307 321 337 340 378 385 420 424 441
202 202 210 214 224 234 253 249 282 281 305 310 321
Operating Profit 56 46 65 71 83 87 84 90 96 104 115 115 119
OPM % 22% 19% 24% 25% 27% 27% 25% 27% 26% 27% 27% 27% 27%
8 5 9 15 9 14 15 17 15 17 27 24 27
Interest 1 1 0 5 2 2 2 3 3 3 3 3 2
Depreciation 14 14 14 14 15 16 16 16 16 20 21 22 21
Profit before tax 49 36 59 67 75 83 81 88 92 98 118 113 123
Tax % 26% 26% 27% 25% 22% 24% 23% 26% 26% 25% 26% 25% 25%
36 27 44 50 59 63 62 65 68 74 87 85 92
EPS in Rs 3.77 2.81 4.54 5.21 6.13 6.54 6.48 6.78 7.12 7.71 8.63 8.41 9.06
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
322 390 411 454 519 610 687 785 922 1,115 1,375 1,670
246 304 323 361 397 479 520 569 707 847 1,013 1,217
Operating Profit 76 86 88 93 122 131 166 216 215 267 362 453
OPM % 24% 22% 21% 21% 23% 22% 24% 28% 23% 24% 26% 27%
11 28 8 14 16 20 21 22 40 38 60 94
Interest 9 10 10 8 12 14 20 11 6 11 14 12
Depreciation 14 19 21 24 29 37 41 48 54 57 64 83
Profit before tax 63 85 65 75 97 100 126 180 195 237 344 453
Tax % 30% 27% 27% 27% 27% 35% 24% 25% 25% 25% 25% 25%
45 62 48 55 71 65 96 136 147 179 258 339
EPS in Rs 5.11 7.07 5.47 6.25 8.00 7.41 10.86 14.17 15.28 18.69 26.91 33.41
Dividend Payout % 20% 18% 27% 40% 25% 27% 18% 18% 16% 16% 11% 10%
Compounded Sales Growth
10 Years: 16%
5 Years: 19%
3 Years: 22%
TTM: 21%
Compounded Profit Growth
10 Years: 22%
5 Years: 29%
3 Years: 34%
TTM: 31%
Stock Price CAGR
10 Years: 26%
5 Years: 43%
3 Years: 45%
1 Year: 5%
Return on Equity
10 Years: 17%
5 Years: 16%
3 Years: 17%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 22 22 22 44 44 44 44 48 48 48 48 51
Reserves 124 174 207 227 294 337 391 918 1,040 1,194 1,422 2,715
67 79 82 101 133 161 207 137 127 149 174 180
73 89 76 85 94 112 126 121 163 187 214 247
Total Liabilities 286 364 387 457 565 654 767 1,224 1,377 1,577 1,859 3,192
123 165 182 207 265 306 363 426 488 635 867 1,096
CWIP 20 10 14 20 18 19 25 21 43 78 76 90
Investments 3 4 4 3 17 8 25 354 346 132 167 1,077
140 185 187 227 264 321 354 422 499 732 748 930
Total Assets 286 364 387 457 565 654 767 1,224 1,377 1,577 1,859 3,192

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
66 63 63 56 75 106 128 119 123 191 266 240
-58 -59 -31 -56 -88 -101 -107 -436 -85 -179 -241 -1,194
5 -6 -31 -0 16 -5 -21 317 -35 -13 -20 951
Net Cash Flow 13 -2 1 0 3 1 1 0 3 -1 5 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 52 59 74 77 79 77 68 72 82 77 72 76
Inventory Days 142 148 114 194 161 186 241 217 218 237 205 188
Days Payable 101 101 76 131 96 123 142 111 115 105 89 57
Cash Conversion Cycle 94 106 111 140 144 139 166 179 185 209 188 207
Working Capital Days 31 45 65 81 94 83 73 107 116 112 100 344
ROCE % 33% 30% 26% 24% 26% 22% 25% 22% 17% 18% 24% 20%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
53.34% 53.33% 53.33% 53.32% 53.32% 53.17% 53.17% 53.14% 66.02% 62.56% 62.44% 62.44%
15.59% 16.27% 16.33% 16.21% 15.61% 14.49% 14.10% 12.37% 9.91% 11.88% 12.33% 11.46%
3.25% 3.39% 3.38% 3.67% 4.25% 5.15% 5.46% 7.21% 9.34% 12.33% 11.66% 11.96%
27.82% 27.02% 26.97% 26.79% 26.82% 27.20% 27.28% 27.25% 14.72% 13.23% 13.57% 14.13%
No. of Shareholders 33,29634,23932,01535,39336,14134,64936,05336,71236,85238,35260,68665,583

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls